Search

A recent report from researchers in Fujian, People's Republic of China, discusses the identification and validation of the hsa_circ_0001726/mir-140-3p/KRAS axis in hepatocellular carcinoma (HCC). The study aimed to construct a circRNA-miRNA-mRNA network in HCC and confirmed the involvement of the hsa_circ_0001726/miR140-3p/KRAS axis in HCC progression and lenvatinib resistance. This research provides new insights into the post-transcriptional regulatory mechanism of HCC, highlighting the potential prognostic value of hsa_circ_0001726 in patients with HCC. [Extracted from the article]

A study conducted by researchers at Fujian Normal University in China has found that machine learning-based surface-enhanced Raman spectroscopy (SERS) can be used for the early detection of lung cancer. The researchers developed a label-free detection strategy using SERS to analyze plasma and exosomes from cancer-free individuals, as well as those with adenocarcinoma in situ and early-stage invasive adenocarcinoma. By training the SERS spectra of plasma and exosomes using machine learning algorithms, the researchers achieved an accuracy higher than 97% and an AUC value higher than 0.9500. The study suggests that the combined SERS "Combined Spectrum" of plasma and exosome has potential for early cancer detection and could be applied to the detection of other diseases as well. [Extracted from the article]

A study conducted at Fujian Medical University in China explored the role of ARHGEF39 in hepatocellular carcinoma (HCC) metastasis. The researchers found that ARHGEF39 is upregulated in HCC and is associated with fatty acid metabolism pathways. They also discovered that ARHGEF39 is a downstream target gene of E2F1. Cell-based experiments showed that high expression of ARHGEF39 promotes HCC cell viability, migration, and invasion through enhanced fatty acid metabolism. The study suggests that ARHGEF39 plays a critical role in HCC metastasis and provides a basis for further research on molecular markers and preventive strategies for HCC metastasis. [Extracted from the article]

A study conducted by Fujian Medical University in China has found that Ga-68-FAPI-RGD PET/CT is more effective than F-18-FDG PET/CT in detecting skull metastasis in a patient with radioiodine-refractory differentiated thyroid cancer. The study focused on a 60-year-old woman who had undergone a total thyroidectomy and subsequent I-131 treatments. The researchers concluded that Lu-177-FAPI-RGD could potentially be used as a treatment option for this type of thyroid cancer. The study has been peer-reviewed and published in Clinical Nuclear Medicine. [Extracted from the article]

A recent report from the Department of Urology in Fujian, China, explores the role of the ECT2 gene in prostate cancer. The study found that ECT2 is highly expressed in prostate cancer cell lines and that its knockdown inhibits cell proliferation, migration, invasion, and glycolysis. The research also discovered that the transcription factor ETS1 directly binds to the ECT2 promoter and positively regulates its expression. These findings suggest that ETS1-induced upregulation of ECT2 enhances the malignant behavior of prostate cancer cells, providing a theoretical basis for potential treatment strategies. [Extracted from the article]

A report from Fujian Medical University in China discusses the use of long non-coding RNAs (lncRNAs) as potential biomarkers for colorectal cancer (CRC). CRC is the third most common cancer globally and the second leading cause of cancer-related death. Due to the lack of specific early symptoms and limitations of current diagnostic methods, most CRC cases are diagnosed at advanced stages. Researchers are exploring lncRNAs as molecular biomarkers for CRC diagnosis and prognosis, as they play critical roles in the development and progression of the disease. The review evaluates the efficacy of lncRNAs with altered expression levels in peripheral blood as diagnostic markers for CRC and summarizes their clinical significance as prognostic markers. The research has been peer-reviewed. [Extracted from the article]

A study conducted by investigators at Fujian Medical University in China examined the relationship between basement membrane-related genes (BMGs) and prognosis in hepatocellular carcinoma (HCC), the most common type of primary liver cancer. The researchers used RNA-seq data from TCGA datasets to identify five genes associated with HCC prognosis. They found that patients with high-risk scores based on the BMGs signature had poorer overall survival and higher levels of immune cell infiltration. The study suggests a potential link between tumor immunity and basement membrane regulation in HCC. [Extracted from the article]

A study conducted by researchers at Fujian Medical University in China investigated the effects of chrysophanol, a phytochemical derived from Radix et Rhizoma Rhei, on HepG2 liver cancer cells. The study found that chrysophanol significantly reduced the proliferation of liver cancer cells by affecting intracellular calcium distribution, diminishing mitochondrial membrane potential, and enhancing the expressions of certain proteins. It also exhibited inhibitory effects on cell migration and wound healing. The researchers concluded that chrysophanol shows potential as a therapeutic agent for liver cancer treatment. This research has been peer-reviewed. [Extracted from the article]

Researchers from Ningde Normal University in Fujian, China have synthesized and characterized two compounds, 1 and 2, which are Keggin-type germanotungstates. These compounds have shown high anti-proliferative activities against gastric, colon, and liver cancer cells. Further investigation revealed that compounds 1 and 2 repressed the STAT3 pathway and its downstream Bcl-2 family proteins, leading to mitochondrial apoptosis. This research provides evidence for the development of antitumor drugs based on germanotungstates. [Extracted from the article]

Researchers from Xiamen University in Fujian, China have conducted a study on the effect of anti-CD3-EGFR bispecific antibody-labeled DC-CIK immune cells on the proliferation of lung cancer cells. The study found that the labeled immune cells had a more severe cytotoxic effect on lung cancer cells compared to the non-labeled cells. In addition, the labeled cells inhibited the growth of lung cancer cells in vitro and showed therapeutic effects in vivo. No adverse reactions were observed during the study. This research provides valuable data for enhancing the therapy of lung cancer. [Extracted from the article]

Researchers from Fujian Medical University in China have developed a flexible photoelectrochemical (PEC) sensor for detecting carcinoembryonic antigen (CEA) in human serum. The sensor, based on In2O3-CdS hierarchical heterojunction, demonstrated high sensitivity and a linear relationship range from 0.002 ng mL-1 to 20 ng mL-1. It also showed better stability and reproducibility compared to commercially available ELISA kits. The researchers believe that this reliable method for early cancer screening and diagnosis has significant potential for improving cancer treatment outcomes and survival rates. [Extracted from the article]

A report from Fuzhou University in Fujian, China discusses new research findings on liposomes in biotechnology. The study focuses on the development of a liposomal complex called ELIG, which combines a contrast agent and a photosensitizer for dual-modal imaging and therapy in non-small cell lung cancer (NSCLC). ELIG demonstrated favorable properties and the ability to monitor drug resistance and predict treatment efficacy. The research holds promise for managing the effectiveness of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in NSCLC therapy. [Extracted from the article]

A recent study conducted at Fujian Medical University in China has developed a nanozyme-based voltammetric sensor for the detection of carcinoembryonic antigen (CEA), a widely used biomarker for various cancers. The researchers synthesized a nanozyme called Pt NPs/Fe-MOF, which exhibited effective catalytic activity. By using CEA aptamer as a specific recognition element, the researchers were able to control the catalytic activity of the nanozyme, resulting in a highly effective sensing method for CEA detection. The sensor demonstrated superior specificity, selectivity, reproducibility, and stability, making it a promising tool for the determination of CEA. [Extracted from the article]

A recent study conducted by researchers at Fujian Medical University in China explored the effects of histone deacetylase 8 (HDAC8) on osteosarcoma, the most common malignant bone cancer. The study found that activation of HDAC8 in osteosarcoma cells can suppress cell viability, proliferation, migration, invasion, and arrest the cell cycle through the TP53 and STAT3/ERK signaling pathways. The researchers concluded that HDAC8 may represent a valuable therapeutic target in osteosarcoma therapy. This research provides valuable insights into potential treatments for osteosarcoma and highlights the importance of further studying HDAC8 in cancer treatment. [Extracted from the article]

A recent study conducted by researchers at Fujian Medical University in China has found that polysaccharides derived from the Pleurotus pulmonarius fungus have the potential to inhibit the growth of glioma cells, a type of brain tumor. The researchers discovered that these polysaccharides can regulate the Hippo signaling pathway and alter the structure of gut microbiota, which may contribute to their anti-tumor effects. The study suggests that Pleurotus pulmonarius polysaccharides could be a natural and safe treatment option for glioma, and may even have probiotic properties. Further research is needed to explore the potential of these polysaccharides in cancer treatment. [Extracted from the article]

A report from Huaqiao University in Fujian, China discusses the use of copper-based nanocomposites in cancer therapy. Copper and copper-based nanomaterials have gained attention for their unique properties and biocompatibility in treating various diseases, including cancer. Researchers have designed and fabricated different types of copper-based nanocomplexes for cancer therapy, such as chemotherapy, radiotherapy, photothermal therapy, chemodynamic therapy, and photodynamic therapy. The development of composite diagnostic nanosystems that integrate multiple treatment methods is seen as significant and promising for the future of anticancer nanomedicines. The report also highlights the challenges and future prospects of copper-based nanocomplexes in clinical translation. [Extracted from the article]

A recent study conducted by researchers at Fujian Medical University in China has investigated the mechanism underlying immune escape in esophageal cancer (EC). The study found that a long non-coding RNA called FOXP4-AS1 was associated with decreased abundance of cytotoxic T lymphocytes (CTLs) and upregulated programmed death-ligand 1 (PD-L1), which facilitated CTL apoptosis in EC. FOXP4-AS1 also inhibited the viability of CTLs and promoted their exhaustion. The study concluded that FOXP4-AS1 promotes CTL exhaustion and immune escape in EC through the stabilization of PD-L1 by the deubiquitinating enzyme USP10. This research provides valuable insights into the development of potential therapeutic strategies for EC. [Extracted from the article]

Researchers from Fujian University of Traditional Chinese Medicine have conducted a study on colorectal cancer (CRC) and the potential of miR-4310 as a biomarker for early screening. The study involved analyzing miRNA expression profiles from the Gene Expression Omnibus database and conducting experiments on CRC tissues and cell lines. The researchers found that miR-4310 was differentially expressed in CRC tissues and had predictive potential for CRC patients. They also discovered that miR-4310 and RUNX1 were involved in the regulation of CRC cells. This research provides valuable insights into the potential use of miR-4310 as a tumor suppressor in colorectal cancer. [Extracted from the article]

Researchers from Fujian Normal University in China have developed a self-position surface-enhanced Raman spectroscopy (SERS) platform combined with machine learning algorithms for precise identification of lung cancer from benign samples. The researchers addressed the challenges of poor signal homogeneity and low throughput in SERS blood analysis by analyzing SERS signals from serum components with different molecular weights. The study achieved a detection accuracy of 96.3% for identifying lung cancer samples. This blood-SERS technology shows promise for clinical cancer detection and could advance the application of SERS in cancer diagnosis. [Extracted from the article]

A study conducted by researchers at Fujian Medical University in China has found that the protein TMPRSS4 plays a significant role in the growth, apoptosis, and metastasis of gallbladder cancer cells. The study used various techniques to evaluate the expression of genes and assess cell growth, migration, and invasion in gallbladder cancer cell lines. The researchers also discovered that honokiol, a compound, inhibits gallbladder cancer proliferation and migration by suppressing TMPRSS4-induced PI3K/AKT activation. The findings suggest that TMPRSS4 could serve as a biomarker for gallbladder cancer. [Extracted from the article]

A study conducted at Huaqiao University in Fujian, China, has developed near-infrared light-powered copper phyllosilicate nanomotors for cuproptosis-based synergistic cancer therapy. These nanomotors, called CuSiO3@Au-Pd NMs, have autonomous mobility and improved cellular uptake and tumor penetration. They release Cu2+ ions that induce a Fenton-like reaction, generating hydroxyl radicals and depleting glutathione within cancer cells. The nanomotors also exhibit photothermal effects, intensifying oxidative stress and cellular apoptosis. In vitro and in vivo experiments have shown that these nanomotors penetrate deeply into tumors and exhibit great anticancer efficacy. This research presents promising potentials for future smart and synergistic cancer therapy. [Extracted from the article]

A new report from Fujian Normal University in China discusses the development of a portable diagnostic tool for detecting a biomarker associated with prostate cancer. The researchers propose a self-calibrating surface-enhanced Raman spectroscopy-based lateral flow immunoassay (SERS-LFA) platform that combines the sensitivity of SERS with the simplicity of LFA. The platform demonstrated improved reproducibility and a lower limit of detection compared to conventional SERS-LFA methods. The researchers believe that this self-calibrated SERS-LFA platform has the potential for early screening of prostate cancer and other diseases. [Extracted from the article]

A study conducted by researchers at Fujian Medical University in China has found that the loss of a protein called keratin 23 (KRT23) enhances the growth inhibitory effect of melatonin in gastric cancer cells. The researchers used microarray analysis to identify differentially expressed genes in gastric cancer cells treated with melatonin. They found that the expression levels of KRT23 were downregulated by melatonin treatment, and that KRT23 knockout led to reduced phosphorylation of ERK1/2 and p38, arrest of the cell cycle, and inhibition of gastric cancer cell proliferation. The researchers suggest that KRT23 may be a potential prognostic biomarker and a novel molecular target for gastric cancer. [Extracted from the article]

A study conducted by Fujian Medical University in China examined the impact of sarcopenia, or muscle loss, on the outcomes of older patients with locally advanced gastric cancer (LAGC) who underwent surgery. The study found that sarcopenia was associated with an increased risk of postoperative complications and lower overall survival and recurrence-free survival rates. The recurrence rate and incidence of distant metastases were also higher in the sarcopenia group. The researchers concluded that assessing the nutritional status of older LAGC patients before surgery and providing thorough postoperative follow-up are important for improving outcomes. [Extracted from the article]

Researchers from Fujian Medical University in China have developed a dual amplification-based electrochemical method for detecting exosomal microRNA (miRNA), which are important biomarkers for cancer diagnosis. The method combines a two-hairpins-based ternary hybridization structure (thTHS)-initiated single-stranded DNA amplification reaction (ssDAR) and sodium perchlorate (NaClO4)-assisted electrocatalytic cycle. This method exhibited a sensitive concentration response with a detection limit of 45 aM and selective miRNA recognition, and successfully detected exosomal miRNA derived from cells and serum. The researchers believe that this method shows promise for detecting and monitoring cancer biomarkers, and it exhibited better discrimination ability between patients with breast cancer and those without. [Extracted from the article]

A study conducted by researchers at Fujian Normal University in Fujian, People's Republic of China, has developed a novel method for the accurate detection of carcinoembryonic antigen (CEA), a tumor marker used in cancer screening. The researchers created a sandwich-type immunosensor using surface-enhanced Raman scattering (SERS) technology. The immunosensor demonstrated high sensitivity, excellent selectivity, and high assay accuracy and precision. The researchers believe that this approach shows promise for early cancer screening and could be further developed for clinical use. [Extracted from the article]

A study conducted by researchers at Minjiang University in Fujian, China, has developed a new nanobiomaterial that can capture and restrain circulating tumor cells (CTC), which are responsible for cancer metastases. The researchers created aptamer-albumin nanobots that can circulate in the blood alongside CTC, increasing their capture efficiency and specificity. The nanobots were found to be biostable and able to escape immune clearance, inhibiting the adhesion, invasion, and cell cycle of CTC and inducing their apoptosis. This proof-of-concept study provides a promising approach to addressing CTC-induced cancer metastases. [Extracted from the article]

A study conducted at Fujian Medical University in China compared two different surgical procedures for low rectal cancer. The study found that there was no significant difference in complications, local recurrence rates, disease-free survival, or overall survival between the two groups. However, two years after ileostomy closure, patients in the straight coloanal anastomosis group had a higher incidence of major low anterior resection syndrome compared to the transverse coloplasty pouch group. The study suggests that transverse coloplasty pouch may be a safer technique that reduces bowel dysfunction after surgery for low rectal cancer. [Extracted from the article]

Researchers at Xiamen University in Fujian, China have conducted a study on the potential anti-human gastric cancer properties of alpinetin, a compound found in a traditional Chinese medicine. The study found that alpinetin exhibited significant therapeutic activities with low systemic toxicity. It also showed inhibitory effects on HMG-CoA reductase and urease, suggesting its potential as an inhibitor of these enzymes. The study concluded that the anti-human gastric carcinoma effect of alpinetin may be attributed to its antioxidant effects. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Anticancer Agents; Apoptosis; Cancer; Cellular Physiology; Drugs and Therapies; Enzymes and Coenzymes; Genetics; Health and Medicine; Kinase; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology; Protective Agents EN Fujian People's Republic of China Asia Anticancer Agents Apoptosis Cancer Cellular Physiology Drugs and Therapies Enzymes and Coenzymes Genetics Health and Medicine Kinase Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology Protective Agents 768 768 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Non-Small Cell Lung Cancer have been presented. For more information on this research see: Pi3k/mtor Inhibitor Vs-5584 Combined With Plk1 Inhibitor Exhibits Synergistic Anti-cancer Effects On Non-small Cell Lung Cancer. [Extracted from the article]

Fujian, People's Republic of China, Asia, Anxiety, Anxiety Disorders, Cancer, China, Health and Medicine, Hematology, Immunoproliferative Disorders, Lymphatic Diseases and Conditions, Lymphoma, Lymphoproliferative Disorders, Mental Health Diseases and Conditions, Oncology Keywords: Fujian; People's Republic of China; Asia; Anxiety; Anxiety Disorders; Cancer; China; Health and Medicine; Hematology; Immunoproliferative Disorders; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Mental Health Diseases and Conditions; Oncology EN Fujian People's Republic of China Asia Anxiety Anxiety Disorders Cancer China Health and Medicine Hematology Immunoproliferative Disorders Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Mental Health Diseases and Conditions Oncology 982 982 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Mental Health Diseases and Conditions - Anxiety Disorders have been published. [Extracted from the article]

According to news originating from Fujian, People's Republic of China, by NewsRx correspondents, research stated, "Gastric cancer is the third most common cause of cancer-related death. Accurate preoperative prediction of lymph node metastasis (LNM) in primary gastric cancer strongly influences the choice of surgical approach and the prognosis of gastric cancer patients." Keywords: Fujian; People's Republic of China; Asia; Cancer; Gastric Cancer; Gastroenterology; Genetics; Health and Medicine; Hemic and Immune Systems; Immunology; Lymph Nodes; Lymphoid Tissue; Oncology; Risk and Prevention EN Fujian People's Republic of China Asia Cancer Gastric Cancer Gastroenterology Genetics Health and Medicine Hemic and Immune Systems Immunology Lymph Nodes Lymphoid Tissue Oncology Risk and Prevention 826 826 1 09/25/23 20230926 NES 230926 2023 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology - Gastric Cancer is the subject of a report. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Biological Factors; CXC Chemokines; Cancer; Carcinomas; Chemokine CXCL10; Chemokine Receptors; Chemokines; Chemotactic Factors; Cytokine Receptors; Cytokines; G-Protein-Coupled Receptors; Health and Medicine; Immunology; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Kidney; Membrane Proteins; Nephrology; Oncology EN Fujian People's Republic of China Asia Biological Factors CXC Chemokines Cancer Carcinomas Chemokine CXCL10 Chemokine Receptors Chemokines Chemotactic Factors Cytokine Receptors Cytokines G-Protein-Coupled Receptors Health and Medicine Immunology Inflammation Mediators Intercellular Signaling Peptides and Proteins Kidney Membrane Proteins Nephrology Oncology 1102 1102 1 08/07/23 20230808 NES 230808 2023 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Carcinomas. The functions of hub-chemokines were mainly enriched in chemokine-mediated signaling pathway, immunocytes chemotaxis and chemokine activity. Fujian, People's Republic of China, Asia, Biological Factors, CXC Chemokines, Cancer, Carcinomas, Chemokine CXCL10, Chemokine Receptors, Chemokines, Chemotactic Factors, Cytokine Receptors, Cytokines, G-Protein-Coupled Receptors, Health and Medicine, Immunology, Inflammation Mediators, Intercellular Signaling Peptides and Proteins, Kidney, Membrane Proteins, Nephrology, Oncology. [Extracted from the article]

Keywords for this news article include: Fujian, People's Republic of China, Asia, Cancer, Carcinomas, Diagnostics and Screening, Health and Medicine, Liver Cancer, Oncology, Fujian Medical University. Keywords: Fujian; People's Republic of China; Asia; Cancer; Carcinomas; Diagnostics and Screening; Health and Medicine; Liver Cancer; Oncology EN Fujian People's Republic of China Asia Cancer Carcinomas Diagnostics and Screening Health and Medicine Liver Cancer Oncology 1015 1015 1 07/31/23 20230801 NES 230801 2023 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Liver Cancer have been published. [Extracted from the article]

For more information on this research see: High-performance Sers Biosensor Based On In-situ Reduction of Silver Nanoparticles In an Ultra-filtration Centrifuge Device for Label-free Detection of Colon Cancer In Serum. Keywords: Fujian; People's Republic of China; Asia; Biosensors; Biotechnology; Cancer; Colon Cancer; Emerging Technologies; Health and Medicine; Nanoparticles; Nanotechnology; Oncology; SERS Biosensors EN Fujian People's Republic of China Asia Biosensors Biotechnology Cancer Colon Cancer Emerging Technologies Health and Medicine Nanoparticles Nanotechnology Oncology SERS Biosensors 1144 1144 1 07/17/23 20230718 NES 230718 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Biosensors have been presented. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Cancer; Diagnostics and Screening; Digestive System Diseases and Conditions; Gastroenterology; Health and Medicine; Oncology; Pancreas; Pancreatic Cancer; Pancreatic Diseases and Conditions; Pancreatic Neoplasms; Pancreatitis EN Fujian People's Republic of China Asia Cancer Diagnostics and Screening Digestive System Diseases and Conditions Gastroenterology Health and Medicine Oncology Pancreas Pancreatic Cancer Pancreatic Diseases and Conditions Pancreatic Neoplasms Pancreatitis 647 647 1 07/17/23 20230718 NES 230718 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Pancreatic Cancer are discussed in a new report. For more information on this research see: Differential Diagnosis of Igg4-related Pancreatitis and Pancreatic Cancer By Mri Features and Its Correlation With Serum Igg4 Level. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Adenocarcinoma; Cancer; Cell Line; Cell Proliferation; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Oncology; Protein Expression; Proteomics EN Fujian People's Republic of China Asia Adenocarcinoma Cancer Cell Line Cell Proliferation Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Oncology Protein Expression Proteomics 814 814 1 07/17/23 20230718 NES 230718 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Lung Cancer have been published. Ziyuglycoside II (ZYG II) has a significant inhibitory effect on the growth of lung cancer cells." The news correspondents obtained a quote from the research from Fujian Medical University, "However, the selective anti-tumor effect of the ZYG II against lung cancer has not been systemically studied. [Extracted from the article]

Western blotting was used to detect the amount of SPTBN2 between glioma tissues and normal brain tissues. Keywords: Fujian; People's Republic of China; Asia; Gliomas; Health and Medicine; Oncology EN Fujian People's Republic of China Asia Gliomas Health and Medicine Oncology 1148 1148 1 07/03/23 20230704 NES 230704 2023 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Gliomas have been published. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Biomarkers; Cancer; Colon Cancer; Diagnostics and Screening; Genetics; Ginsenosides; Health and Medicine; Oncology; Triterpenes EN Fujian People's Republic of China Asia Biomarkers Cancer Colon Cancer Diagnostics and Screening Genetics Ginsenosides Health and Medicine Oncology Triterpenes 273 273 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Colon Cancer are discussed in a new report. ATXN8OS showed high expression in colon cancer cells, and its low expression induced by ginsenoside Rg3 could suppress colon cancer cell invasion and migration. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Gastroenterology; Health and Medicine; Ecology; Enzymes and Coenzymes; Kinase EN Fujian People's Republic of China Asia Gastroenterology Health and Medicine Ecology Enzymes and Coenzymes Kinase 558 558 1 05/29/23 20230530 NES 230530 2023 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Health and Medicine - Gastroenterology is now available. Fujian, People's Republic of China, Asia, Gastroenterology, Health and Medicine, Ecology, Enzymes and Coenzymes, Kinase Keywords for this news article include: Fujian, People's Republic of China, Asia, Gastroenterology, Health and Medicine, Ecology, Enzymes and Coenzymes, Kinase, Fujian Medical University. [Extracted from the article]

Keywords for this news article include: Fujian, People's Republic of China, Asia, Angiogenic Proteins, Cancer, Carcinomas, Growth Factor Receptors, Health and Medicine, Intercellular Signaling Peptides and Proteins, Liver Cancer, Membrane Proteins, Oncology, Receptor Protein-Tyrosine Kinases, VEGF, Vascular Endothelial Growth Factors, Fujian Medical University. Fujian, People's Republic of China, Asia, Angiogenic Proteins, Cancer, Carcinomas, Growth Factor Receptors, Health and Medicine, Intercellular Signaling Peptides and Proteins, Liver Cancer, Membrane Proteins, Oncology, Receptor Protein-Tyrosine Kinases, VEGF, Vascular Endothelial Growth Factors Keywords: Fujian; People's Republic of China; Asia; Angiogenic Proteins; Cancer; Carcinomas; Growth Factor Receptors; Health and Medicine; Intercellular Signaling Peptides and Proteins; Liver Cancer; Membrane Proteins; Oncology; Receptor Protein-Tyrosine Kinases; VEGF; Vascular Endothelial Growth Factors EN Fujian People's Republic of China Asia Angiogenic Proteins Cancer Carcinomas Growth Factor Receptors Health and Medicine Intercellular Signaling Peptides and Proteins Liver Cancer Membrane Proteins Oncology Receptor Protein-Tyrosine Kinases VEGF Vascular Endothelial Growth Factors 548 548 1 05/08/23 20230509 NES 230509 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Liver Cancer. [Extracted from the article]

According to news reporting originating from Fujian, People's Republic of China, by NewsRx correspondents, research stated, "Surface-enhanced Raman spectroscopy (SERS) has shown highly promising for existing cancer screening. Keywords: Fujian; People's Republic of China; Asia; Cancer; Health and Medicine; Oncology; Physics; Power Law EN Fujian People's Republic of China Asia Cancer Health and Medicine Oncology Physics Power Law 274 274 1 05/08/23 20230509 NES 230509 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Cancer. [Extracted from the article]

For more information on this research see: Comparing Strategy of Immune Checkpoint Inhibitors Plus Chemotherapy With Chemotherapy Alone for Small Cell Lung Cancer: a Meta-analysis Based On Six Rcts Incorporating 2800 Participants. Keywords: Fujian; People's Republic of China; Asia; Cancer; Chemotherapy; Drugs and Therapies; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Oncology EN Fujian People's Republic of China Asia Cancer Chemotherapy Drugs and Therapies Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Oncology 777 777 1 04/24/23 20230425 NES 230425 2023 APR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Lung Cancer have been presented. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Antiarrhythmic Agents; Anticancer Agents; Antihypertensives; Antimetastatic; Calcium Channel Blocking Agents; Cancer; Cancer Therapy; Cardiovascular; Cardiovascular Agents; Coagulation Modifiers; Diltiazem Therapy; Drugs and Therapies; Group IV Antiarrhythmics; Health and Medicine; Oncology; Pharmaceuticals; Protective Agents; Thrombolytics; Urokinase Therapy; Vasodilator Agents EN Fujian People's Republic of China Asia Antiarrhythmic Agents Anticancer Agents Antihypertensives Antimetastatic Calcium Channel Blocking Agents Cancer Cancer Therapy Cardiovascular Cardiovascular Agents Coagulation Modifiers Diltiazem Therapy Drugs and Therapies Group IV Antiarrhythmics Health and Medicine Oncology Pharmaceuticals Protective Agents Thrombolytics Urokinase Therapy Vasodilator Agents 479 479 1 04/03/23 20230404 NES 230404 2023 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Drugs and Therapies - Antiarrhythmic Agents is now available. Fujian, People's Republic of China, Asia, Antiarrhythmic Agents, Anticancer Agents, Antihypertensives, Antimetastatic, Calcium Channel Blocking Agents, Cancer, Cancer Therapy, Cardiovascular, Cardiovascular Agents, Coagulation Modifiers, Diltiazem Therapy, Drugs and Therapies, Group IV Antiarrhythmics, Health and Medicine, Oncology, Pharmaceuticals, Protective Agents, Thrombolytics, Urokinase Therapy, Vasodilator Agents. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Cancer; Gastroenterology; Health and Medicine; Oncology; Pancreas; Pancreatic Cancer; Pancreatic Neoplasms EN Fujian People's Republic of China Asia Cancer Gastroenterology Health and Medicine Oncology Pancreas Pancreatic Cancer Pancreatic Neoplasms 794 794 1 04/03/23 20230404 NES 230404 2023 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Pancreatic Cancer. K19 was significantly overexpressed in pancreatic cancer, promoted pancreatic cancer proliferation and metastasis, inhibited tumor cell apoptosis and was associated with poor prognosis. [Extracted from the article]

Keywords for this news article include: Fujian, People's Republic of China, Asia, Cancer, Cell Proliferation, DNA-Binding Proteins, Health and Medicine, NF-kappa B, Nuclear Proteins, Oncology, Proteins, Thyroid Cancer, Thyroid Neoplasms, Transcription Factors, Fujian Medical University. Keywords: Fujian; People's Republic of China; Asia; Cancer; Cell Proliferation; DNA-Binding Proteins; Health and Medicine; NF-kappa B; Nuclear Proteins; Oncology; Proteins; Thyroid Cancer; Thyroid Neoplasms; Transcription Factors EN Fujian People's Republic of China Asia Cancer Cell Proliferation DNA-Binding Proteins Health and Medicine NF-kappa B Nuclear Proteins Oncology Proteins Thyroid Cancer Thyroid Neoplasms Transcription Factors 878 878 1 04/03/23 20230404 NES 230404 2023 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Oncology - Thyroid Cancer are presented in a new report. Fujian, People's Republic of China, Asia, Cancer, Cell Proliferation, DNA-Binding Proteins, Health and Medicine, NF-kappa B, Nuclear Proteins, Oncology, Proteins, Thyroid Cancer, Thyroid Neoplasms, Transcription Factors. [Extracted from the article]

Keywords: Fujian; People's Republic of China; Asia; Cancer; Cancer Detection; Colon Cancer; Cyborgs; Emerging Technologies; Health and Medicine; Machine Learning; Oncology EN Fujian People's Republic of China Asia Cancer Cancer Detection Colon Cancer Cyborgs Emerging Technologies Health and Medicine Machine Learning Oncology 772 772 1 03/27/23 20230328 NES 230328 2023 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Oncology - Cancer Detection. Here, we report on the non-invasive identification of colon cancer (CC) using an internal standard (IS)-calibrated label-free serum SERS assay in combination with machine learning. Keywords for this news article include: Fujian, People's Republic of China, Asia, Cancer, Cancer Detection, Colon Cancer, Cyborgs, Emerging Technologies, Health and Medicine, Machine Learning, Oncology, Fujian Normal University. [Extracted from the article]

The news reporters obtained a quote from the research from Xiamen Huaxia University, 'Thus, we carried out a systematic pan-cancer analysis to explore the relationship between PTBP1 and cancer. Keywords: Fujian; People's Republic of China; Asia; Cancer; Carrier Proteins; Health and Medicine; Oncology; Polypyrimidine Tract-Binding Protein; RNA-Binding Proteins EN Fujian People's Republic of China Asia Cancer Carrier Proteins Health and Medicine Oncology Polypyrimidine Tract-Binding Protein RNA-Binding Proteins Current study results on Cancer have been published. [Extracted from the article]